BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22116139)

  • 1. Prospective evaluation of incidence and severity of oral mucositis induced by conventional chemotherapy in solid tumors and malignant lymphomas.
    Nishimura N; Nakano K; Ueda K; Kodaira M; Yamada S; Mishima Y; Yokoyama M; Terui Y; Takahashi S; Hatake K
    Support Care Cancer; 2012 Sep; 20(9):2053-9. PubMed ID: 22116139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of an elemental diet on oral mucositis of esophageal cancer patients treated with DCF chemotherapy: a multi-center prospective feasibility study (EPOC study).
    Tanaka Y; Ueno T; Yoshida N; Akutsu Y; Takeuchi H; Baba H; Matsubara H; Kitagawa Y; Yoshida K
    Esophagus; 2018 Oct; 15(4):239-248. PubMed ID: 30225745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe oral mucositis associated with cancer therapy: impact on oral functional status and quality of life.
    Cheng KK; Leung SF; Liang RH; Tai JW; Yeung RM; Thompson DR
    Support Care Cancer; 2010 Nov; 18(11):1477-85. PubMed ID: 19916030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy.
    Sunaga T; Nagatani A; Fujii N; Hashimoto T; Watanabe T; Sasaki T
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1317. PubMed ID: 33295153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.
    Blijlevens N; Schwenkglenks M; Bacon P; D'Addio A; Einsele H; Maertens J; Niederwieser D; Rabitsch W; Roosaar A; Ruutu T; Schouten H; Stone R; Vokurka S; Quinn B; McCann S;
    J Clin Oncol; 2008 Mar; 26(9):1519-25. PubMed ID: 18268357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy.
    Peterson DE; Barker NP; Akhmadullina LI; Rodionova I; Sherman NZ; Davidenko IS; Rakovskaya GN; Gotovkin EA; Shinkarev SA; Kopp MV; Kulikov EP; Moiseyenko VM; Gertner JM; Firsov I; Tuleneva T; Yarosh A; Woon CW
    J Clin Oncol; 2009 Sep; 27(26):4333-8. PubMed ID: 19636011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of pain associated with oral mucositis during the acute period after administration of high-dose chemotherapy.
    Cella D; Pulliam J; Fuchs H; Miller C; Hurd D; Wingard JR; Sonis ST; Martin PJ; Giles F
    Cancer; 2003 Jul; 98(2):406-12. PubMed ID: 12872363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk factors for oral mucositis in pediatric patients receiving chemotherapy.
    Curra M; Gabriel AF; Ferreira MBC; Martins MAT; Brunetto AT; Gregianin LJ; Martins MD
    Support Care Cancer; 2021 Nov; 29(11):6243-6251. PubMed ID: 33846825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.
    Rosen LS; Abdi E; Davis ID; Gutheil J; Schnell FM; Zalcberg J; Cesano A; Gayko U; Chen MG; Clarke S
    J Clin Oncol; 2006 Nov; 24(33):5194-200. PubMed ID: 17075109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors of oral mucositis in paediatric and adolescent patients undergoing chemotherapy.
    Cheng KK; Lee V; Li CH; Goggins W; Thompson DR; Yuen HL; Epstein JB
    Oral Oncol; 2011 Mar; 47(3):153-62. PubMed ID: 21220206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Oral Mucositis Occurring During Chemotherapy for Esophageal Cancer Patients Correctly Judged? EPOC Observational Cohort Study.
    Tanaka Y; Ueno T; Yoshida N; Akutsu Y; Takeuchi H; Baba H; Matsubara H; Kitagawa Y; Yoshida K
    Anticancer Res; 2019 Aug; 39(8):4441-4448. PubMed ID: 31366542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy.
    Kim JW; Cha Y; Kim SJ; Han SW; Oh DY; Lee SH; Kim DW; Im SA; Kim TY; Heo DS; Bang YJ
    Support Care Cancer; 2012 Feb; 20(2):395-403. PubMed ID: 21390568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, patient adherence, and costs of oral mucositis in routine care in stem cell transplantation.
    Berger K; Staudenmaier T; Cenzer I; Crispin A; Strobach D; Ostermann H
    Support Care Cancer; 2020 Jul; 28(7):3113-3123. PubMed ID: 31691033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of severe oral mucositis in paediatric cancer patients: a prospective study.
    Otmani N; Alami R; Hessissen L; Mokhtari A; Soulaymani A; Khattab M
    Int J Paediatr Dent; 2011 May; 21(3):210-6. PubMed ID: 21362073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe oral mucositis relating to pain and worse oral condition among patients with solid tumors undergoing treatment with FOLFIRI and 5-FU: a retrospective study.
    Almeida LC; Orcina BDF; Maciel AP; Santos DD; Manzano BR; Santos PSDS
    Sao Paulo Med J; 2022; 140(4):588-594. PubMed ID: 35946677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue.
    Wardley AM; Jayson GC; Swindell R; Morgenstern GR; Chang J; Bloor R; Fraser CJ; Scarffe JH
    Br J Haematol; 2000 Aug; 110(2):292-9. PubMed ID: 10971384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical transforming growth factor-beta3 in the prevention or alleviation of chemotherapy-induced oral mucositis in patients with lymphomas or solid tumors.
    Foncuberta MC; Cagnoni PJ; Brandts CH; Mandanas R; Fields K; Derigs HG; Reed E; Sonis ST; Fay J; LeVeque F; Pouillart P; Schrezenmeier H; Emmons R; Thiel E;
    J Immunother; 2001; 24(4):384-8. PubMed ID: 11565840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy--a randomized controlled trial.
    Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Nigudgi S
    Support Care Cancer; 2013 May; 21(5):1421-8. PubMed ID: 23224689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propolis in the prevention of oral mucositis in breast cancer patients receiving adjuvant chemotherapy: A pilot randomised controlled trial.
    Piredda M; Facchinetti G; Biagioli V; Giannarelli D; Armento G; Tonini G; De Marinis MG
    Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28840622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of clinically relevant oral mucositis in outpatients receiving myelosuppressive chemotherapy for solid tumors.
    Wuketich S; Hienz SA; Marosi C
    Support Care Cancer; 2012 Jan; 20(1):175-83. PubMed ID: 21331484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.